⚠ Evidence warning: Clinical trials or other evidence do not support the claim that methylfolate is a suitable default for any woman planning pregnancy. This page keeps it as a report of what people, websites or other media say.
Spinach for Folate and Pregnancy
Spinach is one of the top common food sources of natural folate — one cup of cooked spinach delivers 263 mcg of dietary folate equivalents (DFE), about 66% of the adult Recommended Dietary Allowance (RDA) and 44% of the 600 mcg pregnancy requirement. The 1991 Medical Research Council (MRC) Vitamin Study definitively proved that 4 mg/day folic acid taken before conception and through the first trimester reduces neural tube defect (NTD) recurrence by 72%. Mandatory folic acid fortification programs have since been followed by reported declines in neural tube defects of 19-55%, according to a 2011 review. This page explores the folate biology of spinach — how dietary folate compares to synthetic folic acid, the methylenetetrahydrofolate reductase (MTHFR) polymorphism story, the methylfolate alternative, and the preparation methods that preserve folate during cooking.
Table of Contents
- Spinach Folate Density vs Other Sources
- Neural Tube Defect Prevention — The Evidence
- Folate vs Folic Acid — The Critical Distinction
- Methylenetetrahydrofolate Reductase Polymorphisms and Methylfolate
- Pregnancy Folate Requirements and Timing
- Beyond Neural Tube Defects — Other Pregnancy Outcomes
- Cooking Losses and Preservation
- Interactions and Cautions
- Folate Intake by Stage of Pregnancy
- Key Research Papers
- Connections
- Featured Videos
Spinach Folate Density vs Other Sources
Folate (vitamin B9) is the natural form of the vitamin found in leafy greens, legumes, and liver. Folic acid is the synthetic oxidized form added to fortified grain products and most multivitamins. Both must ultimately be converted to the active 5-methyltetrahydrofolate (5-MTHF) inside cells, but they take different metabolic routes to get there.
Spinach is one of the top non-fortified, non-liver food sources of folate per calorie. Per the U.S. Department of Agriculture (USDA) FoodData Central database, comparative folate density (mcg DFE per 100 g, cooked unless marked raw):
- Beef liver, braised — 253 mcg DFE per 100 g (highest natural source on this list)
- Lentils, cooked — 181 mcg DFE per 100 g
- Spinach, cooked — 146 mcg DFE per 100 g (about 263 mcg per cup)
- Asparagus, cooked — 149 mcg DFE per 100 g
- Avocado, raw — 81 mcg DFE per 100 g
- Broccoli, cooked — 108 mcg DFE per 100 g
- Kale, cooked — 65 mcg DFE per 100 g
- Romaine lettuce, raw — 136 mcg DFE per 100 g (about 64 mcg per shredded cup, because USDA lists a cup at only 47 g)
What makes spinach particularly useful in practice is the combination of high folate density per gram with relatively neutral flavor and adaptability to many dishes — sauteed as a side, stirred into soups, blended into smoothies, layered into lasagna, or eaten raw in salad. A pregnant woman targeting 600 mcg DFE per day can readily get 200-300 mcg from a single spinach-containing meal, leaving the rest to come from fortified grains, beans, oranges, and a prenatal multivitamin.
The other key advantage of food folate is that it comes packaged with other nutrients that pregnancy demands: iron (though poorly absorbed from spinach), magnesium, vitamin K, beta-carotene, and the carotenoids lutein and zeaxanthin discussed in our eye-health deep-dive.
Neural Tube Defect Prevention — The Evidence
The neural tube — the embryonic structure that becomes the brain and spinal cord — closes between days 21 and 28 after conception, often before many women know they are pregnant. Failure of closure produces a spectrum of defects: anencephaly (incomplete brain development, uniformly fatal at birth), spina bifida (incomplete vertebral column closure with spinal cord exposure, variable severity from mild dimpling to paralysis below the lesion), and encephalocele (brain tissue protruding through skull defect). Globally, a 2018 modelling study estimated 260,100 affected pregnancies in 2015 (uncertainty range 213,800 to 322,000). About half ended in termination or stillbirth, and about 75% of affected babies born alive, an estimated 117,900, died before age 5. A 2022 paper reports that only a quarter of all preventable cases of spina bifida and anencephaly worldwide are currently avoided by food fortification.
The 1991 MRC Vitamin Study Research Group trial (Lancet) was the pivotal randomized controlled trial that established folate's causal role. 1,817 women with a prior neural tube defect-affected pregnancy (high recurrence risk population) were randomized to four arms: folic acid 4 mg/day alone, folic acid plus other vitamins, other vitamins alone, or placebo. The folic acid arms had a recurrence rate of 1.0% versus 3.5% in the non-folic acid arms — a 72% relative reduction. The trial was stopped early on ethical grounds because the benefit was so clear it would have been wrong to continue exposing the control group to elevated risk.
The 1992 Czeizel and Dudas NEJM trial extended the finding to first-occurrence neural tube defects in a general population of Hungarian women. Women planning a pregnancy, in most cases their first, were randomized to a multivitamin containing 0.8 mg folic acid or a trace-element control. Pregnancy was confirmed in 4,753 women, and the outcome was known in 2,104 and 2,052 of them respectively. There were 0 neural tube defect cases in the folic acid group versus 6 in the control group (P=0.029) — statistically significant despite the small absolute numbers because the baseline neural tube defect rate is so low. This confirmed that the protective effect applies to first occurrences, not just recurrence.
A 2015 Cochrane review pooled five studies with 6,708 births and found that daily folic acid, alone or with other vitamins and minerals, prevented neural tube defects (risk ratio 0.31, 95% confidence interval 0.17 to 0.58; high-quality evidence). A risk ratio below 1 means fewer cases in the folic acid group. For recurrence alone, the risk ratio was 0.34 (0.18 to 0.64; four studies, 1,846 births).
Population-level confirmation came from mandatory folic acid fortification of grain products, implemented in the United States and Canada in 1998. A 2011 review by Centers for Disease Control and Prevention authors counted regulations for wheat flour in 53 countries, though in many cases they had not been implemented. It reports decreases of 19-32% in neural tube defect prevalence in the U.S. after fortification, and reported declines of 19-55% in Canada, South Africa, Costa Rica, Chile, Argentina, and Brazil, with the greatest declines in the countries with the highest background prevalence. Mexico and several European Union countries have lagged on fortification due to concerns about masking B12 deficiency in elderly populations — a trade-off with documented downsides for neural tube defect prevention. The United Kingdom's rules now require non-wholemeal wheat flour milled in or imported into the UK to contain folic acid from 13 December 2026, at 0.25 mg per 100 g.
The mechanism of neural tube defect prevention is incompletely understood. Folate is required for the methylation reactions that drive DNA synthesis and homocysteine remethylation. The neural tube closure process is mitotically intense, requiring rapid cell division and tight regulation of methylation-dependent gene expression. Deficient folate produces elevated homocysteine and reduced methylation capacity, both of which appear to interfere with normal neural tube closure. Most affected pregnancies are not in frankly folate-deficient women — the relationship is dose-response across the normal range, and even women with adequate baseline folate benefit from preconceptional supplementation.
Folate vs Folic Acid — The Critical Distinction
Confusingly, the public health literature uses "folate" and "folic acid" interchangeably even though they are different molecules. The distinction matters for absorption, metabolism, and a small subset of patients with genetic variants.
Folate (natural form, present in food including spinach) is actually a family of compounds collectively called folates: tetrahydrofolate (THF), 5,10-methylenetetrahydrofolate, 5-methyltetrahydrofolate (5-MTHF), and various polyglutamates. They differ by oxidation state, the carbon unit attached, and the length of the polyglutamate tail. Intestinal conjugase enzymes cleave the polyglutamate tail to monoglutamate before absorption. Once absorbed, food folates enter the cellular folate pool with minimal additional processing.
Folic acid (synthetic, used in fortified grains and most multivitamins) is fully oxidized monoglutamate that does not occur in nature. It must be reduced by dihydrofolate reductase (DHFR) to dihydrofolate and then to tetrahydrofolate before it can enter the cellular folate pool. DHFR has limited capacity, particularly in the human liver, and excess folic acid can appear unmetabolized in serum at intakes above approximately 200 mcg in a single dose. The clinical significance of circulating unmetabolized folic acid is debated — some studies suggest associations with reduced natural killer cell cytotoxicity and possibly cancer risk in subgroups, but a clear adverse effect has not been established.
The Dietary Folate Equivalent (DFE) system was created to reconcile the two. Under the U.S. Institute of Medicine definition, as quoted by the European Food Safety Authority in 2022, 1 mcg DFE equals 1 mcg of food folate, 0.6 mcg of folic acid from fortified food or a supplement taken with food, or 0.5 mcg of a folic acid supplement taken on an empty stomach. So 1 mcg of folic acid taken with food counts as 1.7 mcg DFE. The adult Recommended Dietary Allowance is 400 mcg DFE.
For preconceptional neural tube defect prevention, the U.S. Centers for Disease Control and Prevention (CDC) recommends 400 mcg folic acid per day. The two trials above used other doses, 4 mg (MRC) and 0.8 mg (Hungary); the 2015 Cochrane review reports that the protective effect was not affected by the daily dose explored, 400 mcg or higher. Food folate alone, even at the same DFE level, has weaker direct trial evidence for neural tube defect prevention, although it is plausibly equivalent if intake is sufficient. The US Preventive Services Task Force, in its 2023 reaffirmation, recommends that all persons planning to or who could become pregnant take a daily supplement containing 0.4 to 0.8 mg (400 to 800 mcg) of folic acid; foods like spinach add to that intake.
Methylenetetrahydrofolate Reductase Polymorphisms and Methylfolate
Methylenetetrahydrofolate reductase (MTHFR) is the enzyme that converts 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate (5-MTHF), the active form used in homocysteine remethylation and methylation reactions. Two common polymorphisms reduce enzyme activity:
- Methylenetetrahydrofolate reductase C677T — heterozygotes (CT) have approximately 65% of wild-type activity; homozygotes (TT) have approximately 30% of activity. The TT genotype is present in approximately 10-15% of Caucasians, up to 25% of Hispanics, and is associated with mildly elevated homocysteine and slight increases in neural tube defect risk in some studies. The 1995 Frosst Nature Genetics paper first identified the variant.
- Methylenetetrahydrofolate reductase A1298C — milder reduction in enzyme activity, generally considered less clinically significant on its own.
The popular wellness narrative around methylenetetrahydrofolate reductase has often overstated the clinical implications. Most TT-homozygotes have entirely normal pregnancy outcomes when consuming adequate folate or folic acid. Practitioners describe L-methylfolate (the L-isomer of 5-MTHF, the bioactive form, sold as a supplement) as the form of choice for TT-homozygotes when any modification is made; it bypasses the methylenetetrahydrofolate reductase conversion step. Some also describe methylfolate as a default for any woman planning pregnancy, regardless of methylenetetrahydrofolate reductase status, because it sidesteps the unmetabolized folic acid concern. In a large trial of folic acid doses in Northern Chinese women, the TT genotype was associated with lower folate concentrations at every dose, and genotype "did not have a significant interaction with folic acid dose."
However, several important caveats apply:
- Routine methylenetetrahydrofolate reductase testing is not recommended by the American College of Medical Genetics or the American College of Obstetricians and Gynecologists because the clinical actionability is limited.
- Methylfolate is more expensive than folic acid and does not have the same direct randomized controlled trial (RCT) evidence base for neural tube defect prevention.
- Food folate from spinach and other natural sources is processed through the normal folate metabolism pathway and provides 5-MTHF naturally — this is one reason food folate may be preferable for individuals concerned about methylenetetrahydrofolate reductase variants.
Pregnancy Folate Requirements and Timing
U.S. Recommended Dietary Allowances for folate:
- Adult women (non-pregnant) — 400 mcg DFE/day
- Pregnant women — 600 mcg DFE/day
- Lactating women — 500 mcg DFE/day
- Preconceptional supplementation — 400 mcg folic acid/day in addition to dietary folate, ideally starting at least 1 month before conception and continued through first trimester
- High-risk women (prior neural tube defect-affected pregnancy, family history of neural tube defects, women on antiepileptic drugs that interfere with folate metabolism) — 4 mg/day folic acid is the dose quoted, starting 1-3 months before conception, and it is the dose used in the MRC trial of women with a prior affected pregnancy. For anyone on an antiseizure medicine, the 2024 neurology guideline described under Interactions and Cautions states at least 0.4 mg daily
Timing is critical. The neural tube closes by day 28 of gestation, which is approximately day 14 after the missed period — before many women realize they are pregnant. By the time a positive pregnancy test prompts a prenatal vitamin start, the window for neural tube defect prevention has typically passed. This is the basis for the U.S. Centers for Disease Control and Prevention recommendation that all women of childbearing age who could become pregnant take 400 mcg folic acid daily, not just those actively trying to conceive.
The US Preventive Services Task Force reaffirmed its recommendation in 2023 (an A recommendation, high certainty of substantial net benefit). Its evidence report of 12 observational studies, covering 1,244,072 people, found no evidence of harms related to multiple births, autism, or maternal cancer.
For women already pregnant, continued adequate folate intake supports red blood cell production, placental development, and fetal growth throughout gestation. Folate deficiency in mid-late pregnancy is associated with megaloblastic anemia, placental abruption, and small-for-gestational-age infants in some studies.
Beyond Neural Tube Defects — Other Pregnancy Outcomes
Folate supplementation in pregnancy has been investigated for several outcomes beyond neural tube defect prevention:
- Congenital heart defects — some observational evidence suggests preconceptional folate may reduce risk of conotruncal heart defects, although the evidence is weaker than for neural tube defects. The 2015 Cochrane review of trials found no clear effect (risk ratio 0.57, 95% confidence interval 0.24 to 1.33; low-quality evidence).
- Cleft lip and palate — case-control studies suggest modest reduction in orofacial cleft risk with periconceptional folate. The 2015 Cochrane review of trials found no clear effect on cleft palate (risk ratio 0.73, 0.05 to 10.89) or cleft lip (risk ratio 0.79, 0.14 to 4.36), on low-quality evidence, and in the Hungarian trial cleft lip with or without cleft palate was not reduced.
- Autism spectrum disorder — in the Norwegian Mother and Child Cohort Study of 85,176 children, the adjusted odds ratio for autistic disorder in children of mothers who took folic acid around conception was 0.61 (95% confidence interval 0.41 to 0.90), with no association for Asperger syndrome or pervasive developmental disorder not otherwise specified, though power was limited. The authors state that the findings "cannot establish causality." Several other observational studies also report lower autism risk. Causality is debated due to potential confounding by other prenatal care behaviors.
- Preterm birth — mixed evidence, with some meta-analyses showing modest reduction in preterm delivery risk with prenatal folate.
- Cognitive development — the FASSTT Offspring Trial (McNulty 2019) found that children whose mothers continued folic acid (400 mcg/day from week 14 to the end of pregnancy) scored higher at age 7 in word reasoning than placebo-arm children (13.3 versus 11.9, p=0.027). Only 70 of 119 potential children were assessed at age 7, and the authors say the supplement "may" benefit cognitive development and that further randomized trials are warranted.
The pattern across these outcomes is that the strongest evidence is for neural tube defect prevention, with weaker but generally supportive evidence for other neurological and structural outcomes. The overall conclusion is that adequate folate intake throughout pregnancy is beneficial beyond the narrow neural tube defect-prevention window.
Cooking Losses and Preservation
Folate is heat-labile and water-soluble, so cooking method matters substantially for folate retention in spinach. The McKillop 2002 British Journal of Nutrition study measured folate retention in spinach, broccoli, beef, and potato. Its abstract reports, for spinach, that boiling left only 49% of the folate (191.8 falling to 94.4 mcg per 100 g) and that steaming caused no significant decrease up to the longest time tested, 4.5 minutes. The list below gives commonly quoted retention figures; the microwave, soup, and saute rows are not in that abstract:
- Raw — 100% folate retention (baseline)
- Steamed (up to 4.5 min) — no significant decrease (McKillop 2002)
- Microwaved with minimal water — 85-95% retention
- Boiled, water discarded — 49% retention (McKillop 2002)
- Boiled in soup, water consumed — 80-90% retention (folate leaches into water but is not lost if consumed)
- Sauteed in oil — 70-80% retention
The single best preparation for folate preservation is steaming or microwaving with minimal water. Boiling halves the folate by leaching it into the cooking water, although the leached folate can be recovered if the cooking water is consumed as soup or broth. Sauteing is intermediate — some folate is lost to heat degradation but no leaching occurs because there is no aqueous medium.
Storage also affects folate. Fresh spinach loses approximately 50% of its folate within 8 days of refrigerated storage. Frozen spinach (blanched briefly before freezing to inactivate enzymes, then frozen quickly) retains folate well — over 80% retention after 6 months at -18°C. Canned spinach has lost most of its folate to the heat sterilization process.
On these figures, folate retention is highest in fresh or frozen spinach that is steamed or quickly sauteed and eaten soon after cooking. The Cooking vs Raw deep-dive has the full per-nutrient cooking analysis.
Interactions and Cautions
- Methotrexate — the antineoplastic and immunosuppressive drug methotrexate is a folate antagonist (inhibits dihydrofolate reductase). High-dose folic acid can interfere with methotrexate's anti-cancer efficacy, but standard-dose folic acid (1-5 mg/day) is often co-prescribed to reduce methotrexate's gastrointestinal and mucosal side effects in rheumatoid arthritis and psoriasis patients. The food folate in spinach at typical intake levels does not interfere with methotrexate therapy.
- Antiepileptic drugs — phenytoin, phenobarbital, primidone, and carbamazepine accelerate folate catabolism and increase neural tube defect risk in pregnancy. A figure of 4 mg/day folic acid is quoted for women on these drugs who could become pregnant. The 2024 guideline from the American Academy of Neurology, American Epilepsy Society, and Society for Maternal-Fetal Medicine states that clinicians should prescribe at least 0.4 mg of folic acid daily before conception and during pregnancy to anyone with epilepsy treated with an antiseizure medicine, to decrease neural tube defect risk and possibly improve the child's neurodevelopment.
- Valproic acid — the same guideline states that clinicians must avoid valproic acid in people with epilepsy who could become pregnant, if clinically feasible, to minimize the risk of major birth defects, neural tube defects, autism, and lower IQ in the child, and that they must consider lamotrigine, levetiracetam, or oxcarbazepine when appropriate. It also reports risks on the other side: clinicians must minimize convulsive seizures during pregnancy because of the risks to parent and fetus, and should exercise caution in removing or replacing a medicine that is controlling the most severe seizure types once a person is already pregnant.
- Sulfasalazine, trimethoprim, triamterene — reduce folate absorption or interfere with folate metabolism. Higher folate intake may be needed.
- Masking of B12 deficiency — high-dose folic acid (typically >1 mg/day) can correct the megaloblastic anemia of B12 deficiency without addressing the underlying B12 deficiency, allowing the neurologic damage of B12 deficiency to progress untreated. This is the basis for the Tolerable Upper Intake Level of 1 mg folic acid per day from supplements in adults. It is the rationale for B12 fortification accompanying folic acid fortification in some countries.
- Spinach is not problematic at any reasonable intake — food folate has no documented upper limit and does not cause the unmetabolized folic acid concern. The only spinach-specific caution in pregnancy is the oxalate content if the patient has a history of calcium oxalate kidney stones — covered in our oxalate deep-dive.
Folate Intake by Stage of Pregnancy
Folate intake by stage, as described in the guidance above and in common prenatal practice:
- Preconception (1-3 months before) — the US Preventive Services Task Force lists a daily supplement with 400-800 mcg folic acid; practitioners describe methylfolate as an alternative if a methylenetetrahydrofolate reductase variant is identified, and common practice adds 1-2 servings of folate-rich food daily (spinach, lentils, asparagus, fortified grains, oranges).
- First trimester — prenatal vitamins usually continue, and the Recommended Dietary Allowance is 600 mcg DFE total folate from supplement plus food. The neural tube closes by day 28, but continued adequate folate supports placental development and erythropoiesis.
- Second and third trimesters — prenatal vitamins and a folate-rich diet usually continue, supporting the dramatic expansion of maternal red cell mass and fetal growth. Per FASSTT Offspring evidence, continued folic acid supplementation may benefit cognitive outcomes.
- Lactation — folate continues at 500 mcg DFE/day to support milk production and replace maternal stores.
For high-risk women (prior neural tube defect pregnancy, antiepileptic drugs, family history), the dose quoted is 4 mg/day folic acid starting 1-3 months before conception through the first trimester — this is prescription strength, not over-the-counter prenatal vitamins. For anyone on an antiseizure medicine, the 2024 neurology guideline states at least 0.4 mg daily.
The US Preventive Services Task Force range is 400-800 mcg folic acid; some prenatal vitamins carry methylfolate instead. Choline (450 mg/day in pregnancy, 550 mg/day lactating) is also important for neural development and is often inadequate in standard prenatal vitamins; the egg yolk and beef liver are the densest food sources. Iodine (220 mcg/day pregnancy) is critical for thyroid hormone synthesis and fetal neurodevelopment.
Key Research Papers
- MRC Vitamin Study Research Group (1991). Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. The Lancet 338:131-137. — PubMed PMID: 1677062
- Czeizel AE, Dudas I (1992). Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. NEJM 327:1832-1835. — PubMed PMID: 1307234
- De-Regil LM et al. (2015). Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Database — PubMed PMID: 26662928
- Frosst P et al. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 10:111-113. — PubMed PMID: 7647779
- Pietrzik K, Bailey L, Shane B (2010). Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics 49:535-548. — PubMed PMID: 20608755
- McKillop DJ et al. (2002). The effect of different cooking methods on folate retention in various foods. British J Nutrition 88:681-688. — PubMed PMID: 12493090
- McNulty H et al. (2019). Effect of continued folic acid supplementation beyond the first trimester of pregnancy on cognitive performance in the child: a follow-up study from a randomized controlled trial (FASSTT Offspring Trial). BMC Medicine 17:196. — PubMed PMID: 31672132
- Crider KS, Yang TP, Berry RJ, Bailey LB (2012). Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. Advances in Nutrition 3:21-38. — PubMed PMID: 22332098
- Bailey LB et al. (2015). Biomarkers of Nutrition for Development — Folate Review. Journal of Nutrition 145:1636S-1680S. — PubMed PMID: 26451605
- Suren P et al. (2013). Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA 309:570-577. — PubMed PMID: 23403681
- Crider KS, Bailey LB, Berry RJ (2011). Folic acid food fortification — its history, effect, concerns, and future directions. Nutrients 3:370-384. — PubMed PMID: 22254102
- Greenberg JA et al. (2011). Folic acid supplementation and pregnancy: more than just neural tube defect prevention. Rev Obstet Gynecol 4:52-59. — PubMed PMID: 22102928
- US Preventive Services Task Force; Barry MJ et al. (2023). Folic Acid Supplementation to Prevent Neural Tube Defects: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA 330:454-459. — PubMed PMID: 37526713
- Viswanathan M, Urrutia RP, Hudson KN, Middleton JC, Kahwati LC (2023). Folic Acid Supplementation to Prevent Neural Tube Defects: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 330:460-466. — PubMed PMID: 37526714
- Pack AM et al. (2025). Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication. Epilepsy Currents 26:64-84. — PubMed PMID: 40083742
- Blencowe H, Kancherla V, Moorthie S, Darlison MW, Modell B (2018). Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis. Annals of the New York Academy of Sciences 1414:31-46. — PubMed PMID: 29363759
- Kancherla V et al. (2022). Preventing birth defects, saving lives, and promoting health equity: an urgent call to action for universal mandatory food fortification with folic acid. Lancet Global Health 10:e1053-e1057. — PubMed PMID: 35617975
- Crider KS et al. (2011). MTHFR 677C→T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation. American Journal of Clinical Nutrition 93:1365-1372. — PubMed PMID: 21508090
- EFSA Panel on Nutrition, Novel Foods and Food Allergens; Turck D et al. (2022). Conversion of calcium-l-methylfolate and (6S)-5-methyltetrahydrofolic acid glucosamine salt into dietary folate equivalents. EFSA Journal 20:e07452. — PubMed PMID: 36034319